KLP Kapitalforvaltning AS bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 34,400 shares of the biotechnology company's stock, valued at approximately $20,445,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Forefront Wealth Management Inc. acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $325,000. Mizuho Securities USA LLC lifted its position in shares of Axon Enterprise by 47.5% in the fourth quarter. Mizuho Securities USA LLC now owns 6,866 shares of the biotechnology company's stock valued at $4,081,000 after acquiring an additional 2,210 shares in the last quarter. Quantbot Technologies LP boosted its stake in shares of Axon Enterprise by 6,924.3% during the 4th quarter. Quantbot Technologies LP now owns 14,751 shares of the biotechnology company's stock worth $8,767,000 after purchasing an additional 14,541 shares during the last quarter. ZEGA Investments LLC purchased a new stake in Axon Enterprise in the 4th quarter worth approximately $384,000. Finally, TD Private Client Wealth LLC boosted its holdings in shares of Axon Enterprise by 42.5% during the fourth quarter. TD Private Client Wealth LLC now owns 1,042 shares of the biotechnology company's stock worth $619,000 after purchasing an additional 311 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have recently commented on AXON. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. Needham & Company LLC reaffirmed a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Finally, Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $604.67.
Check Out Our Latest Stock Report on AXON
Axon Enterprise Stock Up 0.8 %
Shares of AXON traded up $4.66 during trading on Tuesday, reaching $577.18. The company's stock had a trading volume of 436,075 shares, compared to its average volume of 835,213. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $44.23 billion, a price-to-earnings ratio of 149.14, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a fifty day moving average of $591.98 and a two-hundred day moving average of $545.11.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company's stock.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
